|
Exploring Novel Treatments for Rett Syndrome
STATEMENT OF NEED
Rett syndrome is a rare, debilitating neurodevelopmental disorder almost always associated with a spontaneous mutation in the methyl-CpG-binding protein 2 (MECP2) gene on the X-chromosome. Affected individuals experience loss of purposeful hand skills, abnormalities in gait, loss of spoken language, and stereotypic hand movements, with more severe manifestations including seizures, autistic features, autonomic nervous system dysfunction, breathing abnormalities, sleep dist... |
|
|
Everything Cardiac (DVD-ROM)
This program provides a clinically applicable review of cardiovascular physiology and pathophysiology, cardiac assessment, cardiovascular pharmacology and interventions based on current guidelines for the most common cardiac disorders seen in clinical practice. Content includes a review of cardiac physiology that can be applied in daily practice, the physiological basis for cardiovascular drug therapy and the pathophysiology, diagnosis and guideline-based treatment strategies for heart failure... |
|
|
Clinical Questions in Cardiology: Using Glucagon-like Peptite-1 Receptor Agonists
The glucagon-like peptide-1 receptor agonist (GLP-1RA) class of medications has become an important option for treating patients with type 2 diabetes mellitus (T2D). Cardiovascular outcome trials also show that selected GLP-1RAs exert beneficial cardiovascular benefits in patients with and without T2D. In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and th... |
|
|
Nurses Light the Path: Empowering Patients to Improve Breast Cancer Screening and Clinical Trial Representation
Target Audience
The primary target audience for this activity is Oncology Nursing Professionals (APRN, NP, RN).
Program Overview
For women with breast cancer and those at risk, disparities in screening and clinical-trial enrollment exist, particularly among racial and ethnic minority populations. Awareness of these disparities can ensure timely screening practices and help address patient fears and concerns regarding clinical trials that inhibit diverse representation in research. Younger... |
|
|
Recent Advances in the Treatment and Management of Endometrial Cancer
This live activity is designed for oncologists, obstetrics & gynecologists, primary care physicians, nurses and pharmacists engaged in the care of patients with endometrial cancer. This activity will represent a thorough team approach to patient care.
Further, this activity will address the following needs:
Clinicians require a review of risk factors and symptoms of endometrial cancer, as well as appropriate management of patients.
Clinicians need further education regarding new and... |
|
|
Update in Food Allergy Management
Target Audience
This activity has been designed to address the educational needs of pediatric nurse practitioners, pediatricians, and allergists. It may also benefit other clinicians interested in the management of food allergy (FA).
Program Overview
New insights into the immunopathology of FA have led to development of cautious use of controlled exposure to food allergens through allergen immunotherapy and emerging use of monoclonal antibody therapy to interfere with the synthesis of imm... |
|
|
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
STATEMENT OF NEED
Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... |
|
|
Current Standards and New Directions in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
STATEMENT OF NEED
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening thrombotic microangiopathy with a rapid onset and progression and a mortality rate of 10% to 20% with prompt treatment. Onset of aTTP is characterized by severe thrombocytopenia, microangiopathic hemolytic anemia, and a constellation of associated symptoms including hemorrhage, neurologic and renal manifestations, cardiac abnormalities, and mesenteric ischemia (Joly et al, 2017). Survivors of f... |
|
|
New Guidelines and Novel Treatments for PAH: Taking a Forward-Looking Data Dive Into the Pool of Emerging Therapies
Target Audience
This educational activity has been designed to meet the needs of cardiologists, pulmonologists, rheumatologists, and other physicians, including those in primary care and internal medicine, as well as physician assistants, nurse practitioners, and other healthcare providers who may be involved in managing care for patients with pulmonary arterial hypertension (PAH).
Program Overview
Discoveries about the pathogenesis of pulmonary arterial hypertension (PAH) revealed key mo... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology, ophthalmology and family practice. Other members of the care team may also participate.
Program Overview
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subt... |
|
|
Emerging Developments in Human Milk Fortification: Problem Solving for Clinical Practice
Human milk science is evolving at a rapid pace, shaping neonatal nutrition practices significantly. Nonetheless, optimizing growth and development in the NICU remains a challenge. Ariel Salas, MD, MSPH, and Brian Stansfield, MD, are leaders in human milk research, as well as in the clinical application of these findings. In a solutions-based presentation, Drs. Salas and Stansfield present recent clinical trial and real-world data on strategies for optimizing preterm nutrition. In this symposiu... |
|
|
Supporting Neurodevelopment With Brain-Building Nutrition
The brain is one of the fastest growing organs in infants; by the time infants reach 2 years of age, the brain has nearly doubled in size. During this period of time, neurons proliferate, synapses form, and nerve fibers are myelinated"all processes that require support with optimal nutrition. This material reviews the latest learnings on the ways in which nutrition can influence neurodevelopment. Human milk is rich in key lipids for neurodevelopment, which are encapsulated by the milk fat... |
|
|
Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape
Target Audience
This educational activity is directed toward hematologists and hematologist-oncologists, as well as pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with beta-thalassemia.
Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of β-thalassemia, with a forward-looking perspective on how new and novel agents might imp... |
|
|
Ethics for Occupational Therapists
Ethics for Occupational Therapists is a text-based, 3-hour online continuing education (CE/CEU) course that teaches OTs how to address ethical and moral dilemmas in practice.
Ethical and moral issues pervade our lives and healthcare professionals are constantly confronted with a variety of ethical and moral dilemmas. Decisions can have long-range effects professionally and personally, not only for the healthcare professional, but for patients, clients, healthcare entities, and society. Why ... |
|